SL
ALXN

Savior LLC’s Alexion Pharmaceuticals ALXN Stock Holding History

Savior LLC’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-96
Closed -$18K – 866
2021
Q2 		$18K Sell
96
-41
-30% -$7.04K 0.02% 308
2021
Q1 		$21K Hold
137
– – 0.02% 282
2020
Q4 		$21K Hold
137
– – 0.02% 282
2020
Q3 		$16K Sell
137
-45
-25% -$4.86K 0.02% 293
2020
Q2 		$20K Buy
182
+86
+90% +$9.13K 0.03% 237
2020
Q1 		$9K Sell
96
-118
-55% -$11.6K 0.01% 349
2019
Q4 		$23K Buy
+214
New +$22.9K 0.03% 277

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Savior LLC's ALXN Position: Q3 2021 in Review

Savior LLC sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 96 shares — an estimated $18K sold.

Savior LLC first reported a position in ALXN in Q4 2019 and held it in 7 quarters. The position peaked at $23K in Q4 2019. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Savior LLC reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Savior LLC sold 96 Alexion Pharmaceuticals shares in Q3 2021, an estimated $18K.
  • Savior LLC first reported a position in Alexion Pharmaceuticals in Q4 2019 and held it in 7 quarters.
  • Savior LLC's Alexion Pharmaceuticals position peaked at $23K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Savior LLC's 13F filing for Q3 2021, filed 5 Oct 2021.